Cytomegalovirus Disease in HIV-infected Children-A Single-Centre Clinical Experience over 23 Years

Deepti Suri1, Ankur K Jindal1, Aman Gupta1

  • 1Pediatric Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.

Insights

Cytomegalovirus (CMV) disease significantly impacts children with Human Immunodeficiency Virus (HIV). Early screening and ganciclovir treatment for CMV retinitis in these children improve visual outcomes and reduce mortality.

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Immunology

Background:

  • Cytomegalovirus (CMV) infection poses a significant health risk, causing morbidity and mortality in Human Immunodeficiency Virus (HIV)-infected individuals.
  • Limited research exists on pediatric CMV disease, particularly in developing nations.

Purpose of the Study:

  • To investigate the clinical characteristics and outcomes of Cytomegalovirus (CMV) disease in Human Immunodeficiency Virus (HIV)-infected children.
  • To highlight the importance of early detection and treatment strategies for pediatric CMV disease.

Main Methods:

  • A retrospective analysis of medical records was conducted for all Human Immunodeficiency Virus (HIV)-infected children diagnosed with Cytomegalovirus (CMV) disease.
  • Data collected included clinical presentation, CD4+ T cell counts, treatment regimens, and patient outcomes.

Main Results:

  • Fifteen HIV-infected children were diagnosed with CMV disease, predominantly retinitis (100%), with some cases of pneumonia (13.3%) and invasive gastrointestinal disease (6.7%).
  • The median CD4+ T cell count was 64.5 cells/µl. Intravenous ganciclovir was administered for active CMV disease.
  • Mortality occurred in 20% of cases, and 13.3% were lost to follow-up. Early detection through active screening correlated with normal vision outcomes.

Conclusions:

  • Cytomegalovirus retinitis is the most prevalent CMV-related complication in HIV-infected children.
  • Active screening for early detection and prompt initiation of systemic ganciclovir therapy are crucial for reducing morbidity and improving visual prognosis in pediatric CMV disease.
Abstract

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
535
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
674
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
968
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
404
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
635
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
451